Domestic simvastatin market getting heated

With the incessant launchings of patent-expired simvastatin preparations, lipid-lowering agent, fierce competitions between domestic and foreign-invested pharmaceutical firms are being flared up.

Informed sources say that production of simvastatin preparations last year amounted to 70.0 billion won and their output is expected to be a 100 billion won level this year in parallel with the inc...